Alembic Pharmaceuticals reports 25% rise in Q3 consolidated net profit

19 Jan 2021 Evaluate

Alembic Pharmaceuticals has reported results for third quarter ended December 31, 2020.

The company has reported 19.97% rise in its net profit of Rs 277.35 crore for the quarter under review as against net profit of Rs 231.19 crore for the same quarter in the previous year. Total income of the company increased 17.65% at Rs 1238.47 crore for Q3FY21 as compared Rs 1052.65 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported 24.93% rise in its net profit after taxes, non-controlling interests and share of profit of Associates and Joint Ventures at Rs 292.57 crore for the quarter under review as against net profit of Rs 234.19 crore for the same quarter in the previous year. Total income of the company increased by 8.87% at Rs 1316.86 crore for Q3FY21 as compared Rs 1209.54 crore for the corresponding quarter previous year.

Alembic Pharma Share Price

899.90 -2.30 (-0.25%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×